Lite Strategy, Inc. Operating Lease, Expense
Lite Strategy, Inc. (LITS) reported Operating Lease, Expense of $600 for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2022-11-14
- Lite Strategy, Inc. operating lease, expense for the quarter ending 2022-09-30 was $600.00, a 50.00% increase year-over-year.
- Lite Strategy, Inc. operating lease, expense for the quarter ending 2021-09-30 was $400.00.
| Period end | Operating Lease, Expense 3 month |
|---|---|
| 2022-09-30 | $600.00 10-Q · filed 2022-11-14 |
| 2021-09-30 | $400.00 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |